TIDMASH
RNS Number : 5304O
Ashley House PLC
10 February 2016
10 February 2016
Ashley House plc
("Ashley House" or the "Company")
Admission Application Announcement
The Company announces that, with effect from 8:00 a.m. today,
the Company's ordinary shares will commence trading on the ISDX
Growth Market under the ticker ASH.
Ashley House will be quoted on the Social Impact segment of the
ISDX Growth Market and will remain listed on AIM following
admission to ISDX.
Ends
Enquiries:
Ashley House plc 01628 600 340
Antony Walters
Jonathan Holmes
WH Ireland Limited 0207 220 1666
(Nominated Adviser, Corporate Adviser and broker to Ashley House
plc)
Adrian Hadden
Mark Leonard
The following information is provided pursuant to the ISDX
Growth Market Rules for Issuers:
Company Information
The Company is a leading extra care housing and health property
partner working with providers and commissioners in the public,
private & community sectors, and which is admitted to trading
on AIM. The Company has 25 years of providing innovative approaches
in the resourcing, funding, design and development of flexible and
efficient social and community health, care and supported living
environments.
Details of Directors
The full names of the Directors of the Company and positions are
as follows:
Antony Walters, Chief Executive
Antony has a BA in accounting and qualified as a chartered
accountant in 1992. He gained an Executive
MBA by evening study from Warwick University in 2004. He joined
Ashley House in 2010 as Finance
Director having held various senior executive positions within
the Lloyds Pharmacy group, including
leading the corporate acquisitions, property and development
teams. Antony spent 15 months in a pan
European strategic development role based in Germany for Lloyds'
parent company Celesio AG.
Immediately prior to Ashley House, Antony was managing director
of Sapphire Primary Care
Developments Limited which Ashley House acquired from Lloyds
Pharmacy in 2009. Antony was
appointed Chief Executive in October 2014.
Christopher Lyons, Non-Executive Chairman
Christopher has extensive experience in strategic planning,
corporate governance, banking
and housing finance. His career spans 35 years, first with Abbey
National where he held a number of senior
executive positions of increasing importance. He has also led
major infrastructure projects such as the branch development
programme and creating Cahoot, the internet bank.
He then joined the executive Board of Minster Trust Limited, a
fully regulated banking institution
leading the development and launch of an affinity based internet
banking proposition.
Christopher has extensive Non-executive experience chairing
amongst others, the Board
of London Strategic Housing and recently as deputy chairman of
Network Housing Group where
he also chaired the Audit and Risk Committee. He holds a Masters
degree in Strategic Financial
Management and is a visiting fellow at Kingston and Durham
Business Schools. Christopher has
also worked with the NHS Commissioning Board authorising the
recently formed national
network of Commissioning Support Units (CSUs), specifically
assessing and developing business strategies
and the subsequent appointment of their managing directors. He
chaired the advisory
Board for the NHS Yorkshire and Humberside CSU and is currently
a member of the NHS Arden Greater East Midlands CSU Advisory
Board.
Stephen Minion, Non-Executive Deputy Chairman
Stephen is a chartered engineer with a long career in design and
development of commercial property.
Following the award of his degree in engineering he joined the
London Borough of Harrow where he
gained chartered engineer status. He moved to George Wimpey
& Co and learnt his main
"stock in trade" as a property developer before starting his own
company in 1978. In 1991 he
co-founded Ashley House where his specialist knowledge is
invaluable in the delivery of the Company's
core product and the development of new services. Stephen chairs
the Company's Remuneration
Committee and is a Board member of a number of associated
companies.
Jonathan Holmes, Commercial Director
Prior to joining Ashley House in 1998, Jonathan worked in sales
and marketing with an emphasis on setting
up new ventures. In the 1990s he worked in the City for Thomson
Financial Services and latterly the capital
markets and Eurobond regulator ISMA. Jonathan leads the Ashley
House teams that work with clients
and stakeholders to source, structure and develop our projects.
Jonathan is a passionate advocate of
Ashley House's ability to use its status as a profit making plc
to create social value well in excess of its
size and has led Ashley House's involvement as a Founder Member
of the Social Stock Exchange.
Andrew Willetts, Non-executive Director
Andrew has a BA in history from Keble College, Oxford and
qualified as a chartered accountant with
what is now PricewaterhouseCoopers in 1991. He has held senior
financial roles in the retail and
wholesale sectors, including Waterstones and Hagemeyer (now part
of the Rexel group). He joined
Lloyds Pharmacy in 2003, becoming finance director in 2007 and
public sector and healthcare
services director in 2012, with responsibility for the delivery
of pharmacy services and pharmaceutical
supply into NHS hospitals and other public and private sector
organisations. He had Lloyds Pharmacy
Board responsibility for Sapphire Primary Care Developments
until its sale to Ashley House.
Andrew is Chairman of Ashley House's Audit & Risk
Committee.
John Moy, Non-executive Director
John has advised and invested in fast-growing companies for over
20 years including a period sitting
on the panel of Non-executive directors appointed by 3i plc to
their investee companies.
In his industrial career he was both a Chartered Engineer and
Chartered Management Accountant
and was Factory Manager and Financial Controller for Mars
Limited and a UK and Northern Europe
Finance Director for Motorola Inc. He was the Finance Director
of the successful management
buy-in of RHP Bearings. John provides strategic financial
management skills and experience
to the Board.
Sector Classification
Ashley House will be classified as a Health Care Equipment &
Services company on ISDX.
Shareholder Information
Shareholder Number of Shares % Shareholding
------------------------------------------------ ----------------- ---------------
Pershing Nominees 6,000,000 10.29
------------------------------------------------ ----------------- ---------------
Admenta Ltd (Lloyds Pharmacy) 5,493,827 9.42
------------------------------------------------ ----------------- ---------------
John Moy (Non-Executive Director) 4,500,000 7.72
------------------------------------------------ ----------------- ---------------
Stephen Minion (Non-Executive Deputy Chairman) 4,062,825 6.97
------------------------------------------------ ----------------- ---------------
James Moy 3,000,000 5.14
------------------------------------------------ ----------------- ---------------
Mrs. G. Mosley (former director) 2,125,518 3.64
------------------------------------------------ ----------------- ---------------
Jonathan Holmes (Commercial Director) 2,088,736 3.58
------------------------------------------------ ----------------- ---------------
Total Significant Shareholders 27,270,906 46.76
------------------------------------------------ ----------------- ---------------
The Company operates an equity-settled share option scheme under
which it has granted share options to its executive directors and
certain senior managers. The options granted are cancelled in the
event of the option holder leaving the Company. The options held by
directors are set out below:
Director Exercise price Number of options
Antony Walters 9.75p 2,200,000
Jonathan
Holmes 9.75p 2,000,000
4,200,000
------------------
The options, which have an exercise price of 9.75p, will not
become exercisable unless and until the Company's share price
equals or exceeds 37p for a period of at least 90 consecutive
workings days and upon exercise is at or above the 37p
threshold.
The percentage of securities in public hands (as defined in the
ISDX Growth Market Rules for Issuers) is 55.6%. The percentage of
securities not in public hands is 44.4%. There are no restrictions
on the transfer of Ashley House's securities.
Further Information
Ashley House was admitted to trading on AIM on 15 January 2007;
a copy of the admission document dated 12 January 2007 is available
on the Company's website, www.ashleyhouseplc.com.
The Company will remain admitted to trading on AIM following
admission to ISDX. Its ordinary shares are eligible for CREST
settlement. The Company is subject to the UK City Code on Takeovers
and Mergers.
Antony Walters, Chief Executive, commented:
(MORE TO FOLLOW) Dow Jones Newswires
February 10, 2016 02:00 ET (07:00 GMT)
Ashley House (LSE:ASH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ashley House (LSE:ASH)
Historical Stock Chart
From Apr 2023 to Apr 2024
